Presentation ESC 2017 PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease Presenter: Martin J. Holzmann August 28, 2017
News Conference News ESC 2017 CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease Todd Neale August 26, 2017
News Daily News CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition Michael O'Riordan August 04, 2017
News Daily News Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label? Yael L. Maxwell December 23, 2016
News Daily News Guidelines Notwithstanding, More Diabetics with Multivessel CAD Receive PCI Than CABG Yael L. Maxwell May 13, 2016
News Daily News A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG Yael L. Maxwell May 13, 2016
News Daily News Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis Michael O'Riordan April 25, 2016
News Daily News Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes Michael O'Riordan April 25, 2016
News Daily News La Diabetes Influye Más que la Complejidad de la Enfermedad en Pacientes Tratados con SLF L.A. McKeown February 03, 2016
News Daily News Diabetes More Influential Than CAD Complexity in DES-Treated Patients L.A. McKeown February 03, 2016
Presentation Revascularization in Diabetics With Multivessel Disease: Population-Based Evaluation of Outcomes Presenter: Krishnan Ramanathan November 16, 2015
News Conference News ESC 2015 ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff September 09, 2015
News Conference News ESC 2015 FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP Yael L. Maxwell August 30, 2015
Presentation EES vs CABG for Patients With Diabetes and Multivessel Disease Presenter: Sripal Bangalore July 30, 2015